Form 8-K - Current report:
SEC Accession No. 0000885590-21-000038
Filing Date
2021-08-03
Accepted
2021-08-03 07:17:58
Documents
16
Period of Report
2021-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhc-20210803.htm   iXBRL 8-K 41576
2 EX-99.1 ex991-q2x2021.htm EX-99.1 652956
3 EX-99.2 ex992-q2x2021.htm EX-99.2 23783
7 BHC LOGO bauschlogoa08.jpg GRAPHIC 7860
8 BHC LOGO image2.jpg GRAPHIC 7860
  Complete submission text file 0000885590-21-000038.txt   937737

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20210803.xsd EX-101.SCH 1920
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20210803_lab.xml EX-101.LAB 25096
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20210803_pre.xml EX-101.PRE 13047
9 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20210803_htm.xml XML 11421
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 211137964
SIC: 2834 Pharmaceutical Preparations